Albert Bourla Pfizer Inc (PFE) insider trading activity

Albert Bourla is Chairman & CEO of PFIZER INC. Currently has a direct ownership of 327,739 shares of PFE, which is worth approximately $8.64 Million. The most recent transaction as insider was on Feb 23, 2024, when has been sold 112,009 shares (Common Stock) at a price of $27.57 per share, resulting in proceeds of $3,088,088. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 328K

0% 3M change

6.04% 12M change

Total Value Held $8.64 Million

ALBERT BOURLA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 23 2024	SELL Payment of exercise price or tax liability	$3,088,088 $27.57 p/Share	112,009 Reduced 25.47%	327,739 Common Stock
Feb 23 2024	BUY Exercise of conversion of derivative security	$3,490,607 $27.34 p/Share	127,674 Added 22.5%	439,748 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$1,812,743 $41.75 p/Share	43,419 Reduced 12.32%	309,058 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$2,627,305 $42.38 p/Share	61,994 Reduced 14.96%	352,477 Common Stock
Dec 16 2022	BUY Exercise of conversion of derivative security	$5,898,361 $26.53 p/Share	222,328 Added 35.06%	411,890 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$1,041,441 $47.72 p/Share	21,824 Reduced 10.4%	188,017 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$1,758,047 $46.87 p/Share	37,509 Reduced 15.16%	209,841 Common Stock
Dec 17 2021	BUY Exercise of conversion of derivative security	$3,257,266 $26.47 p/Share	123,055 Added 33.3%	246,444 Common Stock
Feb 27 2021	SELL Payment of exercise price or tax liability	$1,494,140 $34.07 p/Share	43,855 Reduced 26.57%	121,179 Common Stock
Feb 27 2021	BUY Exercise of conversion of derivative security	$1,205,224 $22.35 p/Share	53,925 Added 24.63%	165,034 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$4,592,391 $34.29 p/Share	133,928 Reduced 54.66%	111,109 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$3,733,815 $22.86 p/Share	163,334 Added 40.0%	245,037 Common Stock
Nov 09 2020	SELL Open market or private sale	$5,557,385 $41.94 p/Share	132,508 Reduced 62.87%	78,273 Common Stock
Feb 28 2020	SELL Payment of exercise price or tax liability	$831,998 $34.93 p/Share	23,819 Reduced 10.23%	209,069 Common Stock
Feb 28 2020	BUY Exercise of conversion of derivative security	$906,905 $27.37 p/Share	33,135 Added 12.46%	232,888 Common Stock
Feb 26 2020	SELL Payment of exercise price or tax liability	$2,672,202 $35.76 p/Share	74,726 Reduced 27.22%	199,753 Common Stock
Feb 26 2020	BUY Exercise of conversion of derivative security	$3,063,533 $34.59 p/Share	88,567 Added 24.4%	274,479 Common Stock
Feb 27 2019	SELL Payment of exercise price or tax liability	$2,206,437 $42.62 p/Share	51,770 Reduced 15.59%	280,212 Common Stock
Feb 27 2019	BUY Exercise of conversion of derivative security	$2,073,098 $32.23 p/Share	64,322 Added 16.23%	331,982 Common Stock
Feb 27 2019	BUY Grant, award, or other acquisition	-	96,183 Added 26.44%	267,660 Common Stock
Feb 23 2019	SELL Payment of exercise price or tax liability	$846,945 $42.43 p/Share	19,961 Reduced 10.43%	171,477 Common Stock
Feb 23 2019	BUY Exercise of conversion of derivative security	$757,248 $21.03 p/Share	36,008 Added 15.83%	191,438 Common Stock

Albert Bourla

Chairman & CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PFE shares.

Notify only if

Value

Insider Trading

Get notified when an Pfizer Inc insider buys or sells PFE shares.

Notify only if

Operation

Value

Type

News

Receive news related to PFIZER INC

Track Activities on PFE

Account